-
Something wrong with this record ?
Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study
FH. Schjesvold, H. Ludwig, S. Delimpasi, P. Robak, D. Coriu, W. Tomczak, L. Pour, I. Spicka, MA. Dimopoulos, T. Masszi, NG. Chernova, A. Sandberg, M. Thuresson, S. Norin, NA. Bakker, MV. Mateos, PG. Richardson, P. Sonneveld
Language English Country Italy
Document type Clinical Trial, Phase III, Multicenter Study, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 1994
Free Medical Journals
from 1994
Freely Accessible Science Journals
from 1994
PubMed Central
from 2009
Europe PubMed Central
from 2009
Open Access Digital Library
from 1994-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1996
- MeSH
- Drug Resistance, Neoplasm MeSH
- Dexamethasone * therapeutic use administration & dosage MeSH
- Phenylalanine therapeutic use analogs & derivatives MeSH
- Quality of Life * MeSH
- Middle Aged MeSH
- Humans MeSH
- Neoplasm Recurrence, Local drug therapy MeSH
- Multiple Myeloma * drug therapy MeSH
- Antineoplastic Combined Chemotherapy Protocols * therapeutic use adverse effects MeSH
- Recurrence MeSH
- Aged MeSH
- Treatment Outcome MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Clinical Trial, Phase III MeSH
- Multicenter Study MeSH
- Research Support, Non-U.S. Gov't MeSH
Bone Marrow Transplantation Unit and Department of Hematology Evangelismos Hospital Athens Greece
Dana Farber Cancer Institute Boston MA
Department of Hemato Oncology and Bone Marrow Transplantation Medical University of Lublin
Department of Hemato Oncology University Hospital Ostrava Ostrava Czech Republic
Department of Internal Medicine and Haematology Semmelweis University Budapest Hungary
Erasmus MC Cancer Institute Rotterdam
Hospital Clínico Universitario de Salamanca IBSAL CIC Salamanca Spain
National Research Center for Haematology Moscow Russia
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24019945
- 003
- CZ-PrNML
- 005
- 20241024110833.0
- 007
- ta
- 008
- 241015s2024 it f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3324/haematol.2023.284635 $2 doi
- 035 __
- $a (PubMed)38426292
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a it
- 100 1_
- $a Schjesvold, Fredrik H $u Oslo Myeloma Center, Department of Hematology, Oslo University Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway. fredrikschjesvold@gmail.com
- 245 10
- $a Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study / $c FH. Schjesvold, H. Ludwig, S. Delimpasi, P. Robak, D. Coriu, W. Tomczak, L. Pour, I. Spicka, MA. Dimopoulos, T. Masszi, NG. Chernova, A. Sandberg, M. Thuresson, S. Norin, NA. Bakker, MV. Mateos, PG. Richardson, P. Sonneveld
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a protokoly protinádorové kombinované chemoterapie $x terapeutické užití $x škodlivé účinky $7 D000971
- 650 12
- $a dexamethason $x terapeutické užití $x aplikace a dávkování $7 D003907
- 650 _2
- $a chemorezistence $7 D019008
- 650 12
- $a mnohočetný myelom $x farmakoterapie $7 D009101
- 650 _2
- $a lokální recidiva nádoru $x farmakoterapie $7 D009364
- 650 _2
- $a fenylalanin $x terapeutické užití $x analogy a deriváty $7 D010649
- 650 12
- $a kvalita života $7 D011788
- 650 _2
- $a recidiva $7 D012008
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a klinické zkoušky, fáze III $7 D017428
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Ludwig, Heinz $u Department of Medicine I, Center for Medical Oncology and Hematology with Outpatient Department and Palliative Care, Wilhelminen Cancer Research Institute, Vienna
- 700 1_
- $a Delimpasi, Sossana $u Bone Marrow Transplantation Unit and Department of Hematology, Evangelismos Hospital, Athens, Greece
- 700 1_
- $a Robak, Pawel $u Department of Hemato-Oncology, University Hospital Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Coriu, Daniel $u University of Medicine and Pharmacy "Carol Davila", Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania
- 700 1_
- $a Tomczak, Waldemar $u Department of Hemato-Oncology and Bone Marrow Transplantation, Medical University of Lublin
- 700 1_
- $a Pour, Ludek $u Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Babak Myeloma Group, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Spicka, Ivan $u 1st Department of Medicine - Department of Hematology, First Faculty of Medicine, Charles University and General Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Dimopoulos, Meletios-Athanasios $u Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece
- 700 1_
- $a Masszi, Tamas $u Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary
- 700 1_
- $a Chernova, Natalia G $u National Research Center for Haematology, Moscow, Russia
- 700 1_
- $a Sandberg, Anna $u Oncopeptides AB, Stockholm, Sweden
- 700 1_
- $a Thuresson, Marcus $u Oncopeptides AB, Stockholm, Sweden
- 700 1_
- $a Norin, Stefan $u Oncopeptides AB, Stockholm, Sweden
- 700 1_
- $a Bakker, Nicolaas A $u Oncopeptides AB, Stockholm, Sweden
- 700 1_
- $a Mateos, Maria-Victoria $u Hospital Clínico Universitario de Salamanca/IBSAL/CIC, Salamanca, Spain
- 700 1_
- $a Richardson, Paul G $u Dana-Farber Cancer Institute, Boston, MA
- 700 1_
- $a Sonneveld, Pieter $u Erasmus MC Cancer Institute, Rotterdam
- 773 0_
- $w MED00001963 $t Haematologica $x 1592-8721 $g Roč. 109, č. 7 (2024), s. 2331-2336
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38426292 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024110827 $b ABA008
- 999 __
- $a ok $b bmc $g 2202273 $s 1231918
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 109 $c 7 $d 2331-2336 $e 20240701 $i 1592-8721 $m Haematologica $n Haematologica $x MED00001963
- LZP __
- $a Pubmed-20241015